SeNostic GmbH
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Diagnostics
SeNostic is a German biotech company specialized in the field of protein aggregation as for neurodegenerative disorders like Alzheimer, PD and ALS. Our patented technology targets specific biomarkers, pre‑symptomatic, with very high sensitivity and specificity. Our analytic know-how in protein aggregation of our 4 biomarkers supports drug discovery, differential and companion diagnosis as well as patient screening and clustering.
SeNostic provides fundamental innovation for their own pipeline and for the biotech & pharma industry to develop drugs.
After our initial start-up phase since 2023 we are now ready to market with our outstanding performance products. Therefore, we achieved ISO 13485 certification to meet the standards that our partners and customers expect.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}